Does RIBOCICLIB Cause Transaminases increased? 319 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 319 reports of Transaminases increased have been filed in association with RIBOCICLIB (KISQALI). This represents 1.1% of all adverse event reports for RIBOCICLIB.
319
Reports of Transaminases increased with RIBOCICLIB
1.1%
of all RIBOCICLIB reports
37
Deaths
104
Hospitalizations
How Dangerous Is Transaminases increased From RIBOCICLIB?
Of the 319 reports, 37 (11.6%) resulted in death, 104 (32.6%) required hospitalization, and 48 (15.0%) were considered life-threatening.
Is Transaminases increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIBOCICLIB. However, 319 reports have been filed with the FAERS database.
What Other Side Effects Does RIBOCICLIB Cause?
Neutropenia (3,585)
Nausea (3,404)
Fatigue (3,327)
Malignant neoplasm progression (2,468)
Death (2,452)
Vomiting (1,953)
Diarrhoea (1,830)
White blood cell count decreased (1,683)
Pain (1,637)
Metastases to bone (1,538)
What Other Drugs Cause Transaminases increased?
METHOTREXATE (1,236)
ACETAMINOPHEN (929)
ATORVASTATIN (472)
RITUXIMAB (448)
CYCLOPHOSPHAMIDE (401)
PREDNISONE (362)
ADALIMUMAB (340)
PACLITAXEL (333)
ROSUVASTATIN (324)
CARBOPLATIN (319)
Which RIBOCICLIB Alternatives Have Lower Transaminases increased Risk?
RIBOCICLIB vs RIBOFLAVIN
RIBOCICLIB vs RIBOFLAVIN 5'-PHOSPHATE
RIBOCICLIB vs RIBOFLAVIN 5^-PHOSPHATE
RIBOCICLIB vs RIFABUTIN
RIBOCICLIB vs RIFAMPICIN